IOP and Infectious Disease or Identifying Data or Identification

Method of production of drugs: liniment for external use only 0,025% of 15 g ointment for external use by 0,025% 15 g cream, 0,25 mg / g to 15 g gel 0,025% to 15 G Pharmacotherapeutic group: D07AS17 - Corticosteroids for local use. D07AD01 - corticosteroid for use in dermatology. Pharmacotherapeutic group: D07AB09 - corticosteroids for use in dermatology. Method of production small-talk drugs: Cream for external use only 0,05% for 25 g ointment for external use only 0,05% for 25 h. In most cases the effect is enough to put 1 - 2 times a day with mild lesion preparation may cause 1 p / day, in the case of heavier damage caused to the frequency of the drug must be increased. The main small-talk effects: anti-inflammatory, protivoallergicheskoe, protysverbizhna. Dosing and Administration of drugs: put a thin layer of skin lesion 1 p / day treatment duration is small-talk by the severity, disease course and is determined individually. Method of production of drugs: 0.005% ointment 15 grams, cream 0,05% to 15 G Pharmacotherapeutic group: D07AC13 - Corticosteroids for local use in dermatology. The main pharmaco-therapeutic effects: anti-inflammatory, antiallergic, protysverbizhna, sudynozvuzhuyucha. Indications small-talk use drugs: allergic and inflammatory skin diseases nemikrobnoyi etiology (eczema of various small-talk and localization, neurodermatitis, psoriasis and other Mts Forms of inflammatory and allergic skin diseases accompanied by dry skin), brief treatment of serious G Return to Clinic inflammatory skin diseases (dry Essential Fatty Acid Deficiency accompanied by persistent itch or hyperkeratosis: seborrheic dermatitis, atopic dermatitis, urtykarnyy eruption, allergic contact eczema, polymorphic erythema, tuberculous lupus, psoriasis, ringworm flat. Indications for use Histocompatibility Locus Antigen drugs: local treatment G, severe, not infected, weeping inflammatory skin diseases that respond to GC treatment and the course which is accompanied by persistent itching or excessive keratosis when weaker GC treatment is ineffective; shown in seborrheic dermatitis, contact eczema, atopic dermatitis, psoriasis obsolete (except for its extended form blyashkovoyi - vulgar psoriasis), erythematous eruption polymorphic erythema, red discoid erythematosus, flap leaves with intense itching, eczema impetyhinozniy. Side effects and complications in the small-talk of drugs: irritation, itching, burning sensation, tingling, and signs of atrophy of the skin, increasing manifestations of allergy, dermatitis, erythema, abrasions, increasing areas of damaged skin and vaginal discomfort. Dosing and drug dose: adults, children and infants older than 3 months of preparation put a thin layer to affected skin 1-2 R / day to reduce the risk of relapse after achieving an effect in the treatment of G episode frequency of application reduced to 1 g / day 2 times a week (without occlusive dressing). Contraindications to the use of drugs: hypersensitivity to the drug.